AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7536208 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 61
Study 2389112 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium pyrrolidone carboxylate
Number of subjects: 48
Study 2389112 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 7032642 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative serum antisperm antibody titre of 512 or more
Number of subjects: 130
Study 7032642 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative serum antisperm antibody titre below 512
Number of subjects: 130
Study 7032642 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of seminal plasma antibodies
Number of subjects: 130
Study 7032642 — intervention group
Group type: COMPARATOR
Intervention: Per-operative steroids (randomised controlled trial)
Number of subjects: 130
Study 7032642 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall pregnancy rate in partners of men trying to conceive
Number of subjects: 130
Study 7032642 — intervention group
Group type: EXPERIMENTAL
Intervention: Sperm-agglutinating antibodies in serum
Number of subjects: 130
Study 7032642 — intervention group
Group type: EXPERIMENTAL
Intervention: Seminal plasma antibodies before reversal
Number of subjects: 130
Study 31780177 — intervention group
Group type: COMPARATOR
Intervention: Distance from residence to motor vehicle traffic (≥150 m)
Number of subjects: 616
Study 31780177 — intervention group
Group type: EXPERIMENTAL
Intervention: Renovated home
Number of subjects: 616
Study 31780177 — intervention group
Group type: EXPERIMENTAL
Intervention: Air freshener use
Number of subjects: 616
Study 31780177 — intervention group
Group type: EXPERIMENTAL
Intervention: Moldy walls
Number of subjects: 616
Study 31780177 — intervention group
Group type: EXPERIMENTAL
Intervention: Humidifier use
Number of subjects: 616
Study 31260511 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster randomized trials (CRT)
Number of subjects: 0
Study 31260511 — intervention group
Group type: EXPERIMENTAL
Intervention: Community and ICU infection prevention interventions
Number of subjects: 0
Study 31260511 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization by cluster
Number of subjects: 0
Study 28115830 — intervention group
Group type: EXPERIMENTAL
Intervention: ibuprofen arginine
Number of subjects: 36
Study 28115830 — intervention group
Group type: EXPERIMENTAL
Intervention: solubilized ibuprofen capsule
Number of subjects: 36
Study 28115830 — intervention group
Group type: COMPARATOR
Intervention: standard ibuprofen
Number of subjects: 36
Study 25655878 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical fitness parameters (aerobic capacity, anaerobic threshold, anaerobic capacity, isometric and functional muscle strength) in children with bilateral CP
Number of subjects: 46
Study 25655878 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical fitness parameters in children with unilateral CP
Number of subjects: 46
Study 25655878 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical fitness in children with CP
Number of subjects: 46
Study 25697431 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth experience
Number of subjects: 127
Study 25697431 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 127
Study 22111824 — intervention group
Group type: EXPERIMENTAL
Intervention: Needles placed 2.5 cm apart
Number of subjects: 12
Study 22111824 — intervention group
Group type: COMPARATOR
Intervention: Needles placed 5 cm apart
Number of subjects: 12
Study 19406886 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril and indapamide
Number of subjects: 1709
Study 17578311 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture at the right Hegu point (L14)
Number of subjects: 14
Study 17578311 — intervention group
Group type: COMPARATOR
Intervention: Non-acupoint facial points (control group)
Number of subjects: 14
Study 16678450 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate
Number of subjects: 133
Study 16678450 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study 12686336 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat plus a reduced calorie diet (30% of calories from fat)
Number of subjects: 0
Study 12686336 — intervention group
Group type: COMPARATOR
Intervention: Diet-only treatment
Number of subjects: 0
Study 10226960 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic surgery
Number of subjects: 125
Study 10226960 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercises
Number of subjects: 125
Study 10226960 — intervention group
Group type: COMPARATOR
Intervention: Placebo (detuned soft laser)
Number of subjects: 125
Study 10226960 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (including all patients who underwent operation)
Number of subjects: 125
Study 10226960 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain medication status before surgery
Number of subjects: 125
Study 8905804 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg
Number of subjects: 10
Study 8905804 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 1813203 — intervention group
Group type: EXPERIMENTAL
Intervention: Over-the-counter mouthrinses (specific products not detailed)
Number of subjects: 122
Study 1813203 — intervention group
Group type: COMPARATOR
Intervention: Control group (specific product not detailed)
Number of subjects: 122
Study 6613474 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 38
Study 6613474 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 38
Study 29499287 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (40 mg subcutaneous injections every other week)
Number of subjects: 51
Study 29499287 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical injections)
Number of subjects: 51
Study 29499287 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 51
Study 29499287 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 27465383 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant formula milk (IFM) containing 10.5 μg I/100 kcal
Number of subjects: 11
Study 27465383 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant formula milk (IFM) containing 19.3 μg I/100 kcal
Number of subjects: 11
Study 27465383 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant formula milk (IFM) containing 38.5 μg I/100 kcal
Number of subjects: 11
Study 25687352 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-dose edoxaban
Number of subjects: 21105
Study 25687352 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 21105
Study 25687352 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-dose edoxaban
Number of subjects: 21105
Study 23715771 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine contrast-enhanced abdominal CT (n=143)
Number of subjects: 300
Study 23715771 — intervention group
Group type: COMPARATOR
Intervention: Selective imaging practice (SIP) (n=111)
Number of subjects: 300
Study 20720259 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 mg GLP-1
Number of subjects: 12
Study 20720259 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg PYY3-36
Number of subjects: 12
Study 20720259 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 mg GLP-1 plus 1.0 mg PYY3-36
Number of subjects: 12
Study 20720259 — intervention group
Group type: COMPARATOR
Intervention: Placebo (delivery agent alone)
Number of subjects: 12
Study 18789007 — intervention group
Group type: EXPERIMENTAL
Intervention: Acridilol for 24 weeks with other antihypertensive therapy (n=291)
Number of subjects: 592
Study 18789007 — intervention group
Group type: COMPARATOR
Intervention: Stable antihypertensive therapy for 24 weeks (Control group, n=301)
Number of subjects: 592
Study 18789007 — intervention group
Group type: EXPERIMENTAL
Intervention: Acridilol therapy
Number of subjects: 592
Study 18789007 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 592
Study 15991507 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.125% with 1:200000 epinephrine, 20 mL administered through a subphrenic catheter before incision closure and at 4-hourly intervals for the first postoperative 20 hours.
Number of subjects: 0
Study 15991507 — intervention group
Group type: COMPARATOR
Intervention: Saline with 1:200000 epinephrine, 20 mL administered through a subphrenic catheter before incision closure and at 4-hourly intervals for the first postoperative 20 hours.
Number of subjects: 0
Study 12182251 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 100 mg/hydrochlorothiazide 25 mg (L100/25)
Number of subjects: 446
Study 12182251 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg/hydrochlorothiazide 12.5 mg (L50/12.5)
Number of subjects: 446
Study 12182251 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 446
Study 10482058 — intervention group
Group type: EXPERIMENTAL
Intervention: Bordetella pertussis (single agent)
Number of subjects: 155
Study 10482058 — intervention group
Group type: EXPERIMENTAL
Intervention: Bordetella parapertussis (single agent)
Number of subjects: 155
Study 10482058 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlamydia pneumoniae (single agent)
Number of subjects: 155
Study 10482058 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycoplasma pneumoniae (single agent)
Number of subjects: 155
Study 10482058 — intervention group
Group type: EXPERIMENTAL
Intervention: No aetiology found
Number of subjects: 155
Study 10482058 — intervention group
Group type: EXPERIMENTAL
Intervention: Bordetella pertussis (in children with cough for more than 100 days)
Number of subjects: 155
Study 10482058 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular vaccines
Number of subjects: 155
Study 10482058 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 155
Study 8974212 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedure predicting average LDL cholesterol based on serial measurements
Number of subjects: 0
Study 8974212 — intervention group
Group type: COMPARATOR
Intervention: National Cholesterol Education Program recommendation
Number of subjects: 0
Study 1751431 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal social support programme (expressive emotional support through home visits and telephone calls by midwives)
Number of subjects: 1970
Study 1751431 — intervention group
Group type: COMPARATOR
Intervention: Normal antenatal care (Control group)
Number of subjects: 1970
Study 7055344 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture therapy
Number of subjects: 43
Study 7055344 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatments
Number of subjects: 43
Study 31709460 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary cobalt supplementation (0.5-3 mg/kg)
Number of subjects: 0
Study 31709460 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary cobalt supplementation (up to 2 mg/kg)
Number of subjects: 0
Study 31709460 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary cobalt supplementation (3 mg/kg)
Number of subjects: 0
Study 31709460 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary cobalt supplementation (highest level)
Number of subjects: 0
Study 31709460 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary cobalt supplementation
Number of subjects: 0
Study 31709460 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/kg Co dietary supplementation
Number of subjects: 0
Study 31709460 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of dietary cobalt
Number of subjects: 0
Study 31455473 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban (15 mg twice daily for 21 days followed by 20 mg once daily)
Number of subjects: 151
Study 31455473 — intervention group
Group type: COMPARATOR
Intervention: Warfarin (heparin for 3 to 5 days followed by warfarin for 3 to 6 months)
Number of subjects: 151
Study 31455473 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 151
Study 28604652 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nailing guided by digital technology
Number of subjects: 32
Study 28604652 — intervention group
Group type: COMPARATOR
Intervention: Conventional technology
Number of subjects: 32
Study 26346311 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Access Survey Tool (FAST)
Number of subjects: 11992
Study 23589565 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary nitrate (≈ 3.5 mmol)
Number of subjects: 15
Study 23589565 — intervention group
Group type: COMPARATOR
Intervention: Xanthine oxidoreductase (XOR) inhibitor, allopurinol
Number of subjects: 15
Study 23589565 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrite in spontaneously hypertensive rats
Number of subjects: 15
Study 22080312 — intervention group
Group type: EXPERIMENTAL
Intervention: Bodypump training (n = 9)
Number of subjects: 19
Study 22080312 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 19
Study 19109588 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal hemodialysis
Number of subjects: 52
Study 19109588 — intervention group
Group type: COMPARATOR
Intervention: Conventional hemodialysis
Number of subjects: 52
Study 17885936 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 251
Study 17885936 — intervention group
Group type: EXPERIMENTAL
Intervention: Former smokers
Number of subjects: 251
Study 17885936 — intervention group
Group type: EXPERIMENTAL
Intervention: Never smokers
Number of subjects: 251
Study 17885936 — intervention group
Group type: COMPARATOR
Intervention: Nonsmokers with environmental tobacco smoke exposure
Number of subjects: 251
Study 12643888 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol low dose (1.25, 2.5 or 3.75mg/day)
Number of subjects: 2647
Study 12643888 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol moderate dose (5 or 7.5mg/day)
Number of subjects: 2647
Study 12643888 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol high dose (10mg/day)
Number of subjects: 2647
Study 12643888 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol (all doses)
Number of subjects: 2647
Study 12643888 — intervention group
Group type: COMPARATOR
Intervention: Placebo low dose
Number of subjects: 2647
Study 12643888 — intervention group
Group type: COMPARATOR
Intervention: Placebo moderate dose
Number of subjects: 2647
Study 12643888 — intervention group
Group type: COMPARATOR
Intervention: Placebo high dose
Number of subjects: 2647
Study 10777470 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel in combination with cisplatin or carboplatin
Number of subjects: 0
Study 10777470 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel in combination with cisplatin
Number of subjects: 0
Study 10777470 — intervention group
Group type: COMPARATOR
Intervention: Etoposide/cisplatin (previous standard regimen)
Number of subjects: 0
Study 9175967 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline 0.1 microgram kg‐1 min‐1
Number of subjects: 6
Study 9175967 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine 5 micrograms kg‐1 min‐1
Number of subjects: 6
Study 9175967 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopexamine 2 micrograms kg‐1 min‐1
Number of subjects: 6
Study 9175967 — intervention group
Group type: COMPARATOR
Intervention: 5% glucose 0.5 ml kg‐1 h‐1
Number of subjects: 6
Study 1416572 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous octreotide, 100 micrograms every 8 hours for 4 weeks
Number of subjects: 115
Study 1416572 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 micrograms of octreotide daily for 6 months
Number of subjects: 115
Study 1416572 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 micrograms of octreotide daily for 6 months
Number of subjects: 115
Study 1416572 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 115
Study 4014015 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3.3 mg/kg body weight, equivalent to 2 to 3 cups of coffee)
Number of subjects: 15
Study 4014015 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 30925958 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast combined with Budesonide
Number of subjects: 112
Study 30925958 — intervention group
Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 112
Study 28440001 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS + PES
Number of subjects: 92
Study 28440001 — intervention group
Group type: EXPERIMENTAL
Intervention: PES alone
Number of subjects: 92
Study 28440001 — intervention group
Group type: COMPARATOR
Intervention: tDCS alone
Number of subjects: 92
Study 28440001 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 92
Study 26027224 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual intensive therapy (IT)
Number of subjects: 63
Study 26027224 — intervention group
Group type: EXPERIMENTAL
Intervention: Differentiated therapy for improvement of renal function
Number of subjects: 63
Study 23151596 — intervention group
Group type: EXPERIMENTAL
Intervention: mail‐in questionnaire/live telephone interviews (MIP)
Number of subjects: 640
Study 23151596 — intervention group
Group type: EXPERIMENTAL
Intervention: automated telephone with interactive voice recognition
Number of subjects: 640
Study 23151596 — intervention group
Group type: COMPARATOR
Intervention: internet‐based computer Kiosk
Number of subjects: 640
Study 21898603 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilience-oriented intervention
Number of subjects: 39
Study 21898603 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 39
Study 19546826 — intervention group
Group type: EXPERIMENTAL
Intervention: BZA 20 mg/CE 0.45 mg
Number of subjects: 332
Study 19546826 — intervention group
Group type: EXPERIMENTAL
Intervention: BZA 20 mg/CE 0.625 mg
Number of subjects: 332
Study 19546826 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 332
Study 17414346 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 245
Study 17414346 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 245
Study 15224162 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1000 mg administered intravenously 5 min before surgery)
Number of subjects: 40
Study 15224162 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tranexamic acid)
Number of subjects: 40
Study 11213000 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 369
Study 11213000 — intervention group
Group type: COMPARATOR
Intervention: Non-epidural analgesia
Number of subjects: 369
Study 9871930 — intervention group
Group type: EXPERIMENTAL
Intervention: Fick's law with oxygen (FiO2)
Number of subjects: 11
Study 9871930 — intervention group
Group type: EXPERIMENTAL
Intervention: Fick's law with inert gases (FiIG)
Number of subjects: 11
Study 9871930 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermodilution (TH)
Number of subjects: 11
Study 9871930 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiography (E)
Number of subjects: 11
Study 9871930 — intervention group
Group type: COMPARATOR
Intervention: Calculated based on biometrical data (C)
Number of subjects: 11
Study 7885802 — intervention group
Group type: EXPERIMENTAL
Intervention: Moving stimulus figures at 20 cm/sec
Number of subjects: 5
Study 7885802 — intervention group
Group type: COMPARATOR
Intervention: Stationary stimulus figures
Number of subjects: 5
Study 7885802 — intervention group
Group type: EXPERIMENTAL
Intervention: Moving slowly at 10 cm/sec
Number of subjects: 5
Study 7885802 — intervention group
Group type: EXPERIMENTAL
Intervention: Moving fast at 30 cm/sec
Number of subjects: 5
Study 7885802 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimuli moving at speeds ranging from 0 to 45 cm/sec
Number of subjects: 5
Study 1978680 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepindolol TSD
Number of subjects: 14
Study 1978680 — intervention group
Group type: COMPARATOR
Intervention: Transdermal nitrate
Number of subjects: 14
Study 95482 — intervention group
Group type: COMPARATOR
Intervention: Norpace (disopyramide phosphate)
Number of subjects: 120
Study 31588026 — intervention group
Group type: EXPERIMENTAL
Intervention: E-mail alert sent to physician
Number of subjects: 3327
Study 31588026 — intervention group
Group type: COMPARATOR
Intervention: No alert (control group)
Number of subjects: 3327
Study 31009904 — intervention group
Group type: EXPERIMENTAL
Intervention: Real tDCS
Number of subjects: 18
Study 31009904 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 18
Study 28189361 — intervention group
Group type: EXPERIMENTAL
Intervention: Bremelanotide (20 mg) with ethanol (0.6 g/kg)
Number of subjects: 24
Study 28189361 — intervention group
Group type: EXPERIMENTAL
Intervention: Bremelanotide (20 mg) without ethanol
Number of subjects: 24
Study 28189361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 25456099 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glucose treatment
Number of subjects: 1724
Study 25456099 — intervention group
Group type: COMPARATOR
Intervention: Standard glucose treatment
Number of subjects: 1724
Study 23812832 — intervention group
Group type: EXPERIMENTAL
Intervention: Procovery intervention (facilitated mutual support group)
Number of subjects: 0
Study 21451354 — intervention group
Group type: EXPERIMENTAL
Intervention: Judges with high clinical experience (experts)
Number of subjects: 30
Study 21451354 — intervention group
Group type: COMPARATOR
Intervention: Judges with low clinical experience (novices)
Number of subjects: 30
Study 19152943 — intervention group
Group type: EXPERIMENTAL
Intervention: Active ankle positions (plantar position with raised arms)
Number of subjects: 31
Study 19152943 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive ankle positions
Number of subjects: 31
Study 19152943 — intervention group
Group type: COMPARATOR
Intervention: Horizontal foot position
Number of subjects: 31
Study 16813778 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Shuttle Walk Test (MSWT)
Number of subjects: 30
Study 16813778 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimated Vo2max from MSWT
Number of subjects: 30
Study 16813778 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-retest reliability of MSWT
Number of subjects: 30
Study 12950538 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 449